Best Practices in Biopharma Alliances with Digital Therapeutics Partners

2:45 PM - 3:55 PM, Wednesday, October 23, 2019 ・ 2nd Floor
As the FDA has standardized the approval pathway for digital therapeutics, an increasing number of such therapies are reaching patients, often in collaboration with existing biopharma companies. Rock Health released an in-depth study earlier this year identifying four success factors that must be shared for such partnerships: value proposition of the project, organizational commitment, evidence standards, and channel strategy with business model. This session will feature Rock Health’s specific data then discuss the opportunities and challenges with digital therapeutics and biopharma alliance partners themselves.
Speakers
photo
Senior Director for Business Development
Omada Health
photo
Director Digital Health Ventures #G4A
Bayer
photo
Senior Editor
BioCentury Inc.
photo
Senior Director of Investments
Sanofi Ventures
photo
Director of Research and Marketing
Rock Health